414 related articles for article (PubMed ID: 11502639)
1. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Virchow JC
Chest; 2002 Jun; 121(6):2083-4. PubMed ID: 12065391
[No Abstract] [Full Text] [Related]
3. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
[TBL] [Abstract][Full Text] [Related]
4. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
7. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K
J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
[TBL] [Abstract][Full Text] [Related]
8. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
Busse W; Nelson H; Wolfe J; Kalberg C; Yancey SW; Rickard KA
J Allergy Clin Immunol; 1999 Jun; 103(6):1075-80. PubMed ID: 10359889
[TBL] [Abstract][Full Text] [Related]
9. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening AP; Haahtela T; Holgate ST; Picado C; Menten J; Dass SB; Leff JA; Polos PG
BMJ; 2003 Oct; 327(7420):891. PubMed ID: 14563743
[TBL] [Abstract][Full Text] [Related]
10. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
[TBL] [Abstract][Full Text] [Related]
12. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
[TBL] [Abstract][Full Text] [Related]
13. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
Pearlman DS; White MV; Lieberman AK; Pepsin PJ; Kalberg C; Emmett A; Bowers B; Rickard KA; Dorinsky P
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):227-35. PubMed ID: 11868930
[TBL] [Abstract][Full Text] [Related]
14. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
[TBL] [Abstract][Full Text] [Related]
15. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
17. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review.
Joos S; Miksch A; Szecsenyi J; Wieseler B; Grouven U; Kaiser T; Schneider A
Thorax; 2008 May; 63(5):453-62. PubMed ID: 18443162
[TBL] [Abstract][Full Text] [Related]
18. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.
Edelman JM; Turpin JA; Bronsky EA; Grossman J; Kemp JP; Ghannam AF; DeLucca PT; Gormley GJ; Pearlman DS
Ann Intern Med; 2000 Jan; 132(2):97-104. PubMed ID: 10644288
[TBL] [Abstract][Full Text] [Related]
19. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.
Kemp JP; Cook DA; Incaudo GA; Corren J; Kalberg C; Emmett A; Cox FM; Rickard K
J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):188-95. PubMed ID: 9500751
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
Meltzer EO; Lockey RF; Friedman BF; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
Mayo Clin Proc; 2002 May; 77(5):437-45. PubMed ID: 12004993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
